Peter D. Staple

Former Chief Executive Officer at Corium International, Inc.

Peter D. Staple

Peter D. Staple

Former Chief Executive Officer at Corium International, Inc.

Overview
Career Highlights

ALZA Corp.
Chiron Corp.
Corium International, Inc.

RelSci Relationships

487

Number of Boards

3

Birthday

1952

Age

68

Relationships
RelSci Relationships are individuals Peter D. Staple likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Executive Chairman at Corium International, Inc.

Relationship likelihood: Strong

Managing Director at Essex Woodlands Management, Inc.

Relationship likelihood: Strong

Senior Associate Dean for Education at Stanford University

Relationship likelihood: Strong

President & Chief Executive Officer at Corium International, Inc.

Relationship likelihood: Strong

Director & Managing Director at Neuraptive Therapeutics, Inc.

Relationship likelihood: Strong

Counsel at Goodwin Procter LLP

Relationship likelihood: Strong

Venture Partner at Aphelion Capital LLC

Relationship likelihood: Strong

Chief Financial Officer & Principal Accounting Officer at Aimmune Therapeutics, Inc.

Relationship likelihood: Strong

Former Chief Executive Officer at ARYx Therapeutics Inc.

Relationship likelihood: Strong

Co-Founder at Arcutis Biotherapeutics, Inc.

Relationship likelihood: Strong

Paths to Peter D. Staple
Potential Connections via
Relationship Science
You
Peter D. Staple
Former Chief Executive Officer at Corium International, Inc.
Education
J.D. Degree
Class of 1981
B.A Degree
Class of 1974
Career History
Chief Executive Officer
2008 - 2019

Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.

Chief Executive Officer
2002 - 2008

BioSeek, an Asterand company, is improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. Their BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative biological activity profiles for each potential drug. As a result, their technology drives the selection and development of new drug candidates. they leverage their BioMAP® Systems technology in collaborations to enhance the productivity of their pharmaceutical partners' pipelines to identify promising compounds for therapeutic development.Asterand plc acquired BioSeek on February 18, 2010. Asterand is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. BioSeek's BioMAP® platform and primary human cell based assays are highly complementary to the human tissue-based products and services offered by Asterand.Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, Asterand plc is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From their offices in Royston (United Kingdom), San Francisco, California and Detroit, Michigan they have more than 90 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety.

Chief Administrative Officer & General Counsel
1994 - 2002

ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA.

Boards & Committees
Director
2002 - 2008
Political Donations
$250
2000
$250
2000
$250
2000
Investments
Details Hidden

Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Peter D. Staple. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Peter D. Staple's profile does not indicate a business or promotional relationship of any kind between RelSci and Peter D. Staple.